Abstract:Circulation Research, Ahead of Print. Background:Atrial fibrillation (AF), the most common arrhythmia, is associated with the downregulation ofFKBP5(encoding FKBP5 [FK506 binding protein 5]). However, the function of FKBP5 in the heart remains unknown. Here, we elucidate the consequences of cardiomyocyte-restricted loss of FKBP5 on cardiac function and AF development and study the underlying mechanisms.Methods:Right atrial samples from patients with AF were used to assess the protein levels of FKBP5. A cardiomyocyte-specific FKBP5 knockdown mouse model was established by crossbreedingFkbp5flox/floxmice withMyh6MerCreMer/+mice. Cardiac function and AF inducibility were assessed by echocardiography and programmed intracardiac stimulation. Histology, optical mapping, cellular electrophysiology, and biochemistry were employed to elucidate the proarrhythmic mechanisms due to loss of cardiomyocyte FKBP5.Results:FKBP5 protein levels were lower in the atrial lysates of patients with paroxysmal AF or long-lasting persistent chronic AF. Cardiomyocyte-specific knockdown mice exhibited increased AF inducibility and duration compared with control mice. Enhanced AF susceptibility in cardiomyocyte-specific knockdown mice was associated with the development of action potential alternans and spontaneous Ca2+waves, and increased protein levels and activity of the NCX1 (Na+/Ca2+-exchanger 1), mimicking the cellular phenotype of chronic AF patients. FKBP5-deficiency enhanced transcription ofSlc8a1(encoding NCX1) via transcription factor hypoxia-inducible factor 1α. In vitro studies revealed that FKBP5 negatively modulated the protein levels of hypoxia-inducible factor 1α by competitively interacting with heat-shock protein 90. Injections of the heat-shock protein 90 inhibitor 17-AAG normalized protein levels of hypoxia-inducible factor 1α and NCX1 and reduced AF susceptibility in cardiomyocyte-specific knockdown mice. Furthermore, the atrial cardiomyocyte-selective knockdown of FKBP5 was sufficient to enhance AF arrhythmogenesis.Conclusions:This is the first study to demonstrate a role for the FKBP5-deficiency in atrial arrhythmogenesis and to establish FKBP5 as a negative regulator of hypoxia-inducible factor 1α in cardiomyocytes. Our results identify a potential molecular mechanism for the proarrhythmic NCX1 upregulation in chronic AF patients.

FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice

Atrial Fibrillation and Electrophysiology in Transgenic Mice with Cardiac-Restricted Overexpression of FKBP12.

Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release

Sensitized Signalling Between L-type Ca2+channels and Ryanodine Receptors in the Absence or Inhibition of FKBP12.6 in Cardiomyocytes

Oestrogen Protects FKBP12.6 Null Mice from Cardiac Hypertrophy.

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

FKBP12.6 Protects Heart from AngII-induced Hypertrophy Through Inhibiting Ca2+ /Calmodulin-Mediated Signalling Pathways in Vivo and in Vitro.

Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not β-adrenergic stimulation in mouse cardiomyocytes

Fkbp12.6 and Cadpr Regulation of Ca2+ Release in Smooth Muscle Cells

Downregulation of FKBP5 Promotes Atrial Arrhythmogenesis

Localization of the 12.6-kDa FK506-binding Protein (FKBP12.6) Binding Site to the NH2-terminal Domain of the Cardiac Ca2+ Release Channel (Ryanodine Receptor)

FKBP Binding Characteristics of Cardiac Microsomes from Diverse Vertebrates

The immunophilin FK506-binding protein modulates Ca2+ release channel closure in rat heart.

Role of FK506-binding Protein in Ca2+ Spark Regulation

Three Amino Acid Residues Determine Selective Binding of FK506-binding Protein 12.6 to the Cardiac Ryanodine Receptor

Role of FKBP12.6 in Hypoxia- and Norepinephrine-Induced Ca2+ Release and Contraction in Pulmonary Artery Myocytes

FKBP12.6 Regulates The Secretion of Adrenal Chromaffin Cell in Mice

Optical Analysis Of Ryanodine Receptor Behavior In Situ: The Role Of Fkbp12.6 In Cardiomyocytes

PKI-GFP Prevents Cardiac Dysfunction and Myocyte Death Induced by ISO

Cardiac Deficiency of P21-activated Kinase 1 Promotes Atrial Arrhythmogenesis in Mice Following Adrenergic Challenge.

Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.